According to a new market research study titled ‘Transplant Diagnostics Market to 2027 – Global Analysis and Forecasts by Product & Services, Type, Technology, Application, and End User’. The global transplant diagnostics market is expected to reach US$ 1,542.89 Mn in 2027 from US$ 789.88 Mn in 2018. The market is estimated to grow with a CAGR of 7.9% from 2019-2027. The report highlights the trends prevalent in the global transplant diagnostics market and the factors driving the market along with those that act as deterrents to its growth.
Get Sample Copy of the Report at – https://www.theinsightpartners.com/sample/TIPRE00003076/
The market for transplant diagnostics is expected to grow due to factors such as, rising prevalence of cardiovascular diseases, significant growth of biotechnology industries, rising need for the organ transplantation and rising cell based research activities. In addition, the opportunities being offered from emerging nations is likely to have a positive impact on the growth of the market in the coming years.
Global transplant diagnostics market, based on product & services was segmented as, instruments, reagents & consumables and software & services. In 2018, the reagents & consumables segment held the largest share of the market, by product & services. However, the software & services segment is expected to grow at a significant rate during the forecast period. The demand for reagents & consumables is expected to grow significantly during the forecast period owing to the rising need for diagnostic as well as research purposes.
The major players operating in the transplant diagnostics market include, Thermo Fisher Scientific Inc., Abbott, Illumina, Inc., F. Hoffmann-La Roche Ltd, Bio-Rad Laboratories, Inc., bioMérieux SA, QIAGEN, Hologic Inc., Luminex Corporation, and Omixon Inc.
Product launches have been an essential strategy adopted by the industry players in the transplant diagnostics market. For instance, during April, 2018, Qiagen launched QIAstat-Dxâ in Europe. The product launched has played an important role in oncology or transplantation patients and has led to improved treatment decisions. It has also enabled the company to strengthen its presence in Europe region. These developments have helped the company in strengthening its existing product offering in the market, hence assuring a strong presence in the market.
Purchase this Report at – https://www.theinsightpartners.com/buy/TIPRE00003076/
Reasons to Buy the Report:
– Learn about the driving factors, affecting the market growth.
– Imbibe the advancements and progress in the market during the forecast period.
– Understand where the market opportunities lies.
– Compare and evaluate various options affecting the market.
– Pick up on the leading market players within the market.
– Envision the restrictions and restrains that are likely to hamper the market.
The Insight Partners is a one stop industry research provider of actionable intelligence. We help our clients in getting solutions to their research requirements through our syndicated and consulting research services. We are a specialist in Technology, Healthcare, Manufacturing, Automotive and Defense.
Email: [email protected]
This post was originally published on Info Street Wire